{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:18:16Z","timestamp":1787019496206,"version":"build-2736575974"},"reference-count":51,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,11,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Most lymphoblastic lymphomas (LBLs) are regarded as neoplasms of immature T cells because they express cytoplasmic CD3 and frequently carry T-cell receptor (TCR) gene rearrangements. Immature natural killer (NK) and T cells, however, have a common bipotent T\/NK-cell precursor in the thymus, and NK cells also express cytoplasmic CD3. Thus, some LBLs could arise from immature NK cells. Mature NK cells express 2 CD94 transcripts: 1A, induced by interleukin 15 (IL-15), and 1B constitutively. Because immature NK cells require IL-15 for development, CD94 1A transcripts could be a marker of NK-LBL. To test this hypothesis, we used laser capture microdissection to isolate IL-15 receptor \u03b1+ lymphoid cells from the thymus and showed that these cells contained CD94 1A transcripts. We then assessed for CD94 transcripts in 21 cases of LBL that were cytoplasmic CD3+, nuclear terminal deoxynucleotidyl transferase positive (TdT+), and CD56-, consistent with either the T-cell or NK-cell lineage. We found that 7 LBLs expressed CD94 1A transcripts without TCR gene rearrangements, suggesting NK-cell lineage. Patients with NK-LBL were younger than patients with T-LBL (15 years versus 33 years; P = .11) and had a better 2-year survival (100% versus 27%; P &amp;lt; .01). These results improve the current classification of LBL and contribute to our understanding of NK-cell differentiation.<\/jats:p>","DOI":"10.1182\/blood-2005-02-0519","type":"journal-article","created":{"date-parts":[[2005,7,26]],"date-time":"2005-07-26T22:43:33Z","timestamp":1122417813000},"page":"3567-3574","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":20,"title":["CD94 1A transcripts characterize lymphoblastic lymphoma\/leukemia of immature natural killer cell origin with distinct clinical features"],"prefix":"10.1182","volume":"106","author":[{"given":"Chung-Wu","family":"Lin","sequence":"first","affiliation":[{"name":"From the Department of Pathology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; the Department of Obstetrics and Gynecology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; and the Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Yun","family":"Liu","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; the Department of Obstetrics and Gynecology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; and the Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shee-Uan","family":"Chen","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; the Department of Obstetrics and Gynecology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; and the Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Teng","family":"Wang","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; the Department of Obstetrics and Gynecology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; and the Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; the Department of Obstetrics and Gynecology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; and the Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Ming","family":"Hsu","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; the Department of Obstetrics and Gynecology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; and the Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021219320469300_REF1","doi-asserted-by":"crossref","unstructured":"Pilozzi E, Muller-Hermelink HK, Falini B, et al. Gene rearrangement in T-cell lymphoblastic lymphoma. J Pathol. 1999;188: 267-270.","DOI":"10.1002\/(SICI)1096-9896(199907)188:3<267::AID-PATH357>3.0.CO;2-N"},{"key":"2020021219320469300_REF2","doi-asserted-by":"crossref","unstructured":"Michie AM, Carlyle JR, Schmitt TM, et al. Clonal characterization of a bipotent T cell and NK cell progenitor in the mouse fetal thymus. J Immunol. 2000;164: 1730-1733.","DOI":"10.4049\/jimmunol.164.4.1730"},{"key":"2020021219320469300_","doi-asserted-by":"crossref","unstructured":"Ikawa T, Kawamoto H, Fujimoto S, Katsura Y. Commitment of common T\/natural killer (NK) progenitors to unipotent T and NK progenitors in the murine fetal thymus revealed by a single progenitor assay. J Exp Med. 1999;190: 1617-1626.","DOI":"10.1084\/jem.190.11.1617"},{"key":"2020021219320469300_","doi-asserted-by":"crossref","unstructured":"Sanchez MJ, Muench MO, Roncarolo MG, Lanier LL, Philips JH. Identification of a common T\/natural killer cell progenitor in human fetal thymus. J Exp Med. 1994;180: 569-576.","DOI":"10.1084\/jem.180.2.569"},{"key":"2020021219320469300_REF5","doi-asserted-by":"crossref","unstructured":"Sanchez MJ, Spits H, Lanier LL, Philips JH. Human natural killer cell committed thymocytes and their relation to the T cell lineage. J Exp Med. 1993;178: 1857-1866.","DOI":"10.1084\/jem.178.6.1857"},{"key":"2020021219320469300_REF6","doi-asserted-by":"crossref","unstructured":"Philips JH, Hori T, Nagler A, Bhat N, Spits H, Lanier LL. Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3 epsilon, delta proteins. J Exp Med. 1992;175: 1055-1066.","DOI":"10.1084\/jem.175.4.1055"},{"key":"2020021219320469300_REF7","doi-asserted-by":"crossref","unstructured":"Melinda K, Garrett KP, Thompson LF, Rossi MID, Payne KJ, Kincade PW. Identification of very early lymphoid precursors in bone marrow and their regulation by estrogen. Nat Immunol. 2001;2: 718-724.","DOI":"10.1038\/90659"},{"key":"2020021219320469300_REF8","unstructured":"Adriaansen HJ, Soeting PW, Wolvers-Tettero IL, van Dongen JJ. Immunoglobulin and T-cell receptor gene rearrangements in acute non-lymphocytic leukemias. Analysis of 54 cases and a review of the literature. Leukemia. 1991;5: 744-751."},{"key":"2020021219320469300_REF9","doi-asserted-by":"crossref","unstructured":"Nakamura F, Tatsumi E, Kawano S, et al. Acute lymphoblastic leukemia\/lymphoblastic lymphoma of natural killer (NK) lineage: quest for another NK-lineage neoplasm. Blood. 1997;89: 4665-4666.","DOI":"10.1182\/blood.V89.12.4665"},{"key":"2020021219320469300_REF10","doi-asserted-by":"crossref","unstructured":"Emile JF, Boulland ML, Haioun C, et al. CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood. 1996;87: 1466-1473.","DOI":"10.1182\/blood.V87.4.1466.bloodjournal8741466"},{"key":"2020021219320469300_REF11","doi-asserted-by":"crossref","unstructured":"Chaperot L, Bendriss N, Manches O, et al. Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood. 2001;97: 3210-3217.","DOI":"10.1182\/blood.V97.10.3210"},{"key":"2020021219320469300_","doi-asserted-by":"crossref","unstructured":"Feuillard J, Jacob MC, Valensi F, et al. Clinical and biologic features of CD4(+)CD56(+) malignancies. Blood. 2002;99: 1556-1563.","DOI":"10.1182\/blood.V99.5.1556"},{"key":"2020021219320469300_REF13","doi-asserted-by":"crossref","unstructured":"Leroux D, Mugneret F, Callanan M, et al. CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Francais de Cytogenetique Hematologique. Blood. 2002;99: 4154-4159.","DOI":"10.1182\/blood.V99.11.4154"},{"key":"2020021219320469300_REF14","doi-asserted-by":"crossref","unstructured":"Giorda R, Rudert WA, Vavassori C, Chambers WH, Hiserodt JC, Trucco M. NKR-P1, a signal transduction molecule on natural killer cells. Science. 1990;249: 1298-1300.","DOI":"10.1126\/science.2399464"},{"key":"2020021219320469300_","doi-asserted-by":"crossref","unstructured":"Giorda R, Weisberg EP, Ip TK, Trucco M. Genomic structure and strain-specific expression of the natural killer cell receptor NKR-P1. J Immunol. 1992;149: 1957-1963.","DOI":"10.4049\/jimmunol.149.6.1957"},{"key":"2020021219320469300_REF16","doi-asserted-by":"crossref","unstructured":"Yokoyama WM, Seaman WE. The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Annu Rev Immunol. 1993;11: 613-663.","DOI":"10.1146\/annurev.iy.11.040193.003145"},{"key":"2020021219320469300_REF17","doi-asserted-by":"crossref","unstructured":"Khalturin K, Becker M, Rinkevich B, Bosch TC. Urochordates and the origin of natural killer cells: identification of a CD94\/NKR-P1-related receptor in blood cells of Botryllus. Proc Natl Acad Sci U S A. 2003;100: 622-627.","DOI":"10.1073\/pnas.0234104100"},{"key":"2020021219320469300_REF18","doi-asserted-by":"crossref","unstructured":"Schwarzler C, Oliferenko S, Gunthert U. Variant isoforms of CD44 are required in early thymocyte development. Eur J Immunol. 2001;31: 2997-3005.","DOI":"10.1002\/1521-4141(2001010)31:10<2997::AID-IMMU2997>3.0.CO;2-J"},{"key":"2020021219320469300_REF19","doi-asserted-by":"crossref","unstructured":"Lien HC, Lin CW, Huang PH, Chang ML, Hsu SM. Expression of cyclin-dependent kinase 6 (cdk6) and frequent loss of CD44 in nasal-naso-pharyngeal NK\/T-cell lymphomas: comparison with CD56-negative peripheral T-cell lymphomas. Lab Invest. 2000;80: 893-900.","DOI":"10.1038\/labinvest.3780093"},{"key":"2020021219320469300_REF20","doi-asserted-by":"crossref","unstructured":"Liu CC, Perussia B, Young JD. The emerging role of IL-15 in NK-cell development. Immunol Today. 2000;21: 113-116.","DOI":"10.1016\/S0167-5699(99)01581-9"},{"key":"2020021219320469300_REF21","doi-asserted-by":"crossref","unstructured":"Mrozek E, Anderson P, Caligiuri MA. Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood. 1996;87: 2632-2640.","DOI":"10.1182\/blood.V87.7.2632.bloodjournal8772632"},{"key":"2020021219320469300_REF22","doi-asserted-by":"crossref","unstructured":"Yokota Y, Mansouri A, Mori S, et al. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature. 1999;397: 702-706.","DOI":"10.1038\/17812"},{"key":"2020021219320469300_REF23","doi-asserted-by":"crossref","unstructured":"Ikawa T, Fujimoto S, Kawamoto H, Katsura Y, Yokota Y. Commitment to natural killer cells requires the helix-loop-helix inhibitor Id2. Proc Natl Acad Sci U S A. 2001;98: 5164-5169.","DOI":"10.1073\/pnas.091537598"},{"key":"2020021219320469300_","doi-asserted-by":"crossref","unstructured":"Leclercq G, Debacker V, de Smedt M, Plum J. Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotential T\/natural killer progenitor cells. J Exp Med. 1996;184: 325-336.","DOI":"10.1084\/jem.184.2.325"},{"key":"2020021219320469300_","doi-asserted-by":"crossref","unstructured":"Greenbaum S, Zhuang Y. Regulation of early lymphocyte development by E2A family proteins. Semin Immunol. 2002;14: 405-414.","DOI":"10.1016\/S1044532302000751"},{"key":"2020021219320469300_REF26","doi-asserted-by":"crossref","unstructured":"Langerak AW, Wolvers-Tettero IL, van Gastel-Mol EJ, Oud ME, van Dongen JJ. Basic helix-loop-helix proteins E2A and HEB induce immature T-cell receptor rearrangements in nonlymphoid cells. Blood. 2001;98: 2456-2465.","DOI":"10.1182\/blood.V98.8.2456"},{"key":"2020021219320469300_REF27","doi-asserted-by":"crossref","unstructured":"Morrow MA, Mayer EW, Perez CA, Adlam M, Siu G. Overexpression of the helix-loop-helix protein Id2 blocks T cell development at multiple stages. Mol Immunol. 1999;36: 491-503.","DOI":"10.1016\/S0161-5890(99)00071-1"},{"key":"2020021219320469300_REF28","doi-asserted-by":"crossref","unstructured":"Engel I, Murre C. The function of E- and ID proteins in lymphocyte development. Nat Rev Immunol. 2001;1: 193-199.","DOI":"10.1038\/35105060"},{"key":"2020021219320469300_REF29","doi-asserted-by":"crossref","unstructured":"DiSanto JP. Cytokines: shared receptors, distinct functions. Curr Biol. 1997;7: R424-426.","DOI":"10.1016\/S0960-9822(06)00208-9"},{"key":"2020021219320469300_REF30","doi-asserted-by":"crossref","unstructured":"Rothenberg EV. T-lineage specification and commitment: a gene regulation perspective. Semin Immunol. 2002;14: 431-440.","DOI":"10.1016\/S1044532302000787"},{"key":"2020021219320469300_REF31","unstructured":"Schilham MW, Wilson A, Moerer P, Benaissa-Trouw BJ, Cumano A, Clevers HC. Critical involvement of Tcf-1 in expansion of thymocytes. Immunology. 1998;161: 3984-3991."},{"key":"2020021219320469300_REF32","doi-asserted-by":"crossref","unstructured":"Ioannidis V, Beermann F, Clevers H, Held W. The B-catenin-TCF-1 pathway ensures CD4+CD8+ thymocyte survival. Nat Immunol. 2001;2: 691-697.","DOI":"10.1038\/90623"},{"key":"2020021219320469300_REF33","doi-asserted-by":"crossref","unstructured":"Toor AA, Lund TC, Miller JS. T-cell factor-1 expression during human natural killer cell development and in circulating CD56(+) bright natural killer cells. Exp Hematol. 2001;29: 499-506.","DOI":"10.1016\/S0301-472X(00)00680-9"},{"key":"2020021219320469300_REF34","doi-asserted-by":"crossref","unstructured":"Chang C, Rodriguez A, Carretero M, Lopez-Botet M, Phillips JH, Lanier LL. Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily. Eur J Immunol. 1995;9: 2433-2437.","DOI":"10.1002\/eji.1830250904"},{"key":"2020021219320469300_","doi-asserted-by":"crossref","unstructured":"Lopez-Botet M, Perez-Villar JJ, Carreterro M, et al. Structure and function of the CD94 C-type lectin receptor complex involved in recognition of HLA class I molecules. Immunol Rev. 1997;155: 165-174.","DOI":"10.1111\/j.1600-065X.1997.tb00949.x"},{"key":"2020021219320469300_REF36","doi-asserted-by":"crossref","unstructured":"Long EO, Rajagopalan S. HLA class I recognition by killer cell Ig-like receptors. Semin Immunol. 2000;12: 101-108.","DOI":"10.1006\/smim.2000.0212"},{"key":"2020021219320469300_REF37","doi-asserted-by":"crossref","unstructured":"Lieto LD, Borrego F, You CH, Coligan JE. Human CD94 gene expression: dual promoters differing in responsiveness to IL-2 and IL-15. J Immunol. 2003;171: 5277-5286.","DOI":"10.4049\/jimmunol.171.10.5277"},{"key":"2020021219320469300_REF38","doi-asserted-by":"crossref","unstructured":"Wilhelm BT, Landry JR, Takei F, Mager DL. Transcriptional control of murine CD94 gene: differential usage of dual promoters by lymphoid cell types. J Immunol. 2003;171: 4219-4226.","DOI":"10.4049\/jimmunol.171.8.4219"},{"key":"2020021219320469300_REF39","doi-asserted-by":"crossref","unstructured":"Lin CW, Lee WH, Chang CL, Yang JY, Hsu SM. Restricted killer cell immunoglobulin-like receptor repertoire without T-cell receptor gamma rearrangement supports a true natural killer-cell lineage in a subset of sinonasal lymphomas. Am J Pathol.2001;159: 1671-1679.","DOI":"10.1016\/S0002-9440(10)63014-3"},{"key":"2020021219320469300_REF40","doi-asserted-by":"crossref","unstructured":"Lin CW, Yang JY, Chuang YC, Chen YH, Albitar M, Hsu SM. Presence of restricted killer immunoglobulin-like receptor repertoire and monoclonal T-cell receptor gamma rearrangement as evidence of mixed NK\/T-cell differentiation in a subset of sinonasal lymphomas. Lab Invest. 2003;83: 55-64.","DOI":"10.1097\/01.LAB.0000047491.62596.A3"},{"key":"2020021219320469300_REF41","doi-asserted-by":"crossref","unstructured":"Yokoyama WM, Kim S, French AR. The dynamic life of natural killer cells. Annu Rev Immunol. 2004;22: 405-429.","DOI":"10.1146\/annurev.immunol.22.012703.104711"},{"key":"2020021219320469300_REF42","doi-asserted-by":"crossref","unstructured":"Tu X, Baffa R, Luke S, Prisco M, Baserga R. Intracellular redistribution of nuclear and nucleolar proteins during differentiation of 32D murine hemopoietic cells. Exp Cell Res. 2003;288: 119-130.","DOI":"10.1016\/S0014-4827(03)00178-2"},{"key":"2020021219320469300_REF43","doi-asserted-by":"crossref","unstructured":"Engel I, Murre C. Disruption of pre-TCR expression accelerates lymphomagenesis in E2A-deficient mice. Proc Natl Acad Sci U S A. 2002;99: 11322-11327.","DOI":"10.1073\/pnas.162373999"},{"key":"2020021219320469300_","doi-asserted-by":"crossref","unstructured":"Park ST, Nolan GP, Sun XH. Growth inhibition and apoptosis due to restoration of E2A activity in T cell acute lymphoblastic leukemia cells. J Exp Med. 1999;189: 501-508.","DOI":"10.1084\/jem.189.3.501"},{"key":"2020021219320469300_REF45","doi-asserted-by":"crossref","unstructured":"Hunger SP. Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis. Blood. 1996;87: 1211-1224.","DOI":"10.1182\/blood.V87.4.1211.bloodjournal8741211"},{"key":"2020021219320469300_REF46","doi-asserted-by":"crossref","unstructured":"Miller JS, McCullar V. Human natural killer cells with polyclonal lectin and immunoglobulin-like receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2\/L3\/S2. Blood. 2001;98: 705-713.","DOI":"10.1182\/blood.V98.3.705"},{"key":"2020021219320469300_REF47","doi-asserted-by":"crossref","unstructured":"Held W, Clevers H, Grosschedl R. Redundant functions of TCF-1 and LEF-1 during T and NK cell development, but unique role of TCF-1 for Ly49 NK cell receptor acquisition. Eur J Immunol. 2003;33: 1393-1398.","DOI":"10.1002\/eji.200323840"},{"key":"2020021219320469300_REF48","doi-asserted-by":"crossref","unstructured":"Dorfman DM, Greisman HA, Shahsafaei A. Loss of expression of the WNT\/beta-catenin-signaling pathway transcription factors lymphoid enhancer factor-1 (LEF-1) and T cell factor-1 (TCF-1) in a subset of peripheral T cell lymphomas. Am J Pathol. 2003;162: 1539-1544.","DOI":"10.1016\/S0002-9440(10)64287-3"},{"key":"2020021219320469300_REF49","doi-asserted-by":"crossref","unstructured":"O'Keeffe J, Doherty DG, Kernna T, et al. Diverse populations of T cells with NK cell receptors accumulate in the human intestine in health and in colorectal cancer. Eur J Immunol. 2004;34: 2110-2119.","DOI":"10.1002\/eji.200424958"},{"key":"2020021219320469300_REF50","doi-asserted-by":"crossref","unstructured":"Sheibani K, Winberg CD, Burke JS, et al. Lymphoblastic lymphoma expressing natural killer cell-associated antigens: a clinicopathologic study of six cases. Leuk Res. 1987;11: 371-377.","DOI":"10.1016\/0145-2126(87)90183-4"},{"key":"2020021219320469300_REF51","unstructured":"Chan JKC, Jaffe ES, Ralfkiaer E. Blastic NK-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001: 214-215."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/10\/3567\/1636537\/zh802205003567.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/10\/3567\/1636537\/zh802205003567.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T17:11:49Z","timestamp":1683133909000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/106\/10\/3567\/20929\/CD94-1A-transcripts-characterize-lymphoblastic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,15]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,11,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-02-0519","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,15]]}}}